Pembrolizumab in Treating Patients With Recurrent Glioblastoma
Clinical trial NCT02337686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02337686
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-28
- Primary completion
- 2017-05-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.